Bioavailability what can and Cannot Be Claimed
Pick up any two omega-3 supplements and one of them will probably claim to be "better absorbed." Bioavailability is the supplement industry's favourite way to imply superiority without proving it. "Better absorbed," "more bioavailable," "clinically proven absorption" appear on labels with a frequency that far outpaces the evidence behind them.
What our research found
Chlorella protein digestibility rises from 35 per cent to 70-84 per cent with cell wall processing. That is genuine and measurable. But "improved digestibility" and "more bioavailable" are not the same claim. Bioavailability requires demonstrating that the nutrient reaches your bloodstream and is used by your body, not just that it escapes the cell wall.
Iron from chlorella is non-haem, with lower absorption than haem iron from meat. Pairing with vitamin C improves uptake, but the bioavailability is inherently lower. B12 bioavailability is confounded by the pseudocobalamin issue: standard assays overstate what your body can actually use.
We describe what we know and stop where the evidence stops. ULTANA's EPA exists in a polar lipid matrix that may have favourable absorption characteristics, but product-specific human data does not exist. We describe the structural difference and do not make the absorption claim. That restraint costs us sales, but the alternative is a promise we cannot verify.
What a Bioavailability Claim Actually Requires
A legitimate bioavailability superiority claim needs a head-to-head comparison: your product versus a comparator, at matched doses, in a randomised human trial, measuring blood levels of the nutrient over a defined period, published in a peer-reviewed journal. That is a high bar. Most supplement companies claiming "better absorption" have not cleared it.
What they usually have is one of the following, presented as though it were equivalent:
- An in vitro dissolution study showing their format dissolves faster in simulated gastric fluid. Dissolution is not absorption. Your gut is not a beaker.
- A comparison with a different product at a different dose, which confuses format superiority with dose superiority.
- A general reference to published literature on the lipid form without product-specific data. That literature is covered honestly in our phospholipids vs triglycerides article.
- Nothing at all, relying on you not asking.
What Can Honestly Be Said About Algae Product Bioavailability
Clean Omega DHA: published research on algae-derived DHA shows comparable absorption to fish-derived DHA (Ryan and Symington, 2015). That is ingredient-level evidence. It does not mean the specific product is better absorbed than fish oil without a product-specific trial.
ULTANA Phytoplankton: the EPA exists in a whole-cell polar lipid matrix, structurally different from triglyceride-bound fish oil EPA. Some researchers hypothesise this form may have favourable absorption, and the hypothesis is reasonable. But product-specific bioavailability data does not exist. We describe the structural difference and stop short of the claim. The variables that affect absorption are covered in our absorption guide.
Fermented chlorella: fermentation breaks down the cell wall more thoroughly than mechanical cracking, which should improve nutrient accessibility. "Should" is the operative word. The mechanism is plausible but published comparison data on fermented versus standard chlorella bioavailability in humans is limited. We make the cell-wall argument, which is well-established, but not a quantified absorption superiority claim.
The Chlorella Digestibility Data and Its Limits
The digestibility improvement from cell wall processing is one of the most commonly cited numbers in chlorella marketing: protein digestibility rising from roughly 35 per cent in whole-cell chlorella to 70-84 per cent in processed forms. That figure is real and comes from published feeding studies.
The limit is in what it proves. Digestibility measures how much of a nutrient becomes physically accessible during digestion. Bioavailability measures how much reaches your bloodstream and performs a biological function. A nutrient can be fully digestible and still poorly absorbed if it competes with other compounds for transport, requires conversion to an active form, or is in a chemical state your intestine handles inefficiently.
We use the digestibility figure because it is honest. We do not use it to imply full bioavailability because that is a larger claim the data does not support.
Why Drawing the Line Matters More Than the Claim
Once you claim "better absorbed" and cannot prove it, everything else you say becomes less credible. We think it is more useful to tell you what is known (structural differences, plausible mechanisms, ingredient-level evidence) and what is not known (product-specific human bioavailability data) than to make a confident claim the evidence does not fully support.
Our approach to claim boundaries is described in our evidence hub. Bioavailability is one of the areas where the temptation to overclaim is strongest, because "better absorbed" is what consumers want to hear, and that desire is powerful even when the data is weak.
What You Should Ask Any Supplement Making Bioavailability Claims
Is the comparison dose-matched? A product delivering 500mg EPA in triglyceride form will put more EPA in your blood than 100mg in phospholipid form, regardless of absorption rate. If the doses are not matched, the comparison tells you nothing about the format.
Is the evidence product-specific or format-general? "Phospholipid omega-3 is better absorbed" is not the same as "this specific product is better absorbed." The former may be supported by literature. The latter requires a trial on the actual product.
Was the study published and independently reviewed? Data on a company website with no external peer review has not been scrutinised. Manufacturer-funded research is not invalid, but it warrants the same scrutiny you would apply to any industry-funded work.
Bioavailability Claims FAQs
Does dissolution in a lab mean my body will absorb the nutrient?
No. Dissolution measures how quickly a substance breaks down in simulated fluid. Absorption involves transport across the intestinal lining, competition with other compounds, and delivery to target tissues. A fast-dissolving tablet may still produce lower blood levels than a slower one if the nutrient is poorly transported or rapidly metabolised.
Can format-general research prove that a specific product is better absorbed?
No. Literature showing that phospholipid-bound omega-3 has higher uptake than triglyceride-bound omega-3 in controlled trials does not automatically apply to a specific commercial capsule. The product may differ in dose, purity, matrix composition, or processing from what was tested. Product-specific data is the standard for a product-specific claim.
What does "clinically proven absorption" usually mean in practice?
It often means less than it implies. Check whether the clinical evidence is for the exact product or for the ingredient category. Check whether the trial was dose-matched, peer-reviewed, and independently funded. In many cases, the phrase refers to a single small study or to format-level literature rather than a rigorous product-specific trial.
Does Phytality claim its products are better absorbed than competitors?
No. We describe structural features (polar lipid matrix for EPA, fermented cell wall for chlorella) and cite ingredient-level research where it exists. We do not make product-specific absorption superiority claims because we have not conducted product-specific bioavailability trials. We consider this the honest position.
Is chlorella iron as bioavailable as iron from meat?
No. Chlorella provides non-haem iron, which is absorbed less efficiently than haem iron from animal sources. Vitamin C taken at the same meal improves non-haem iron uptake. If you rely on chlorella as an iron source, pairing it with a vitamin C-rich food or drink makes a measurable difference to how much iron reaches your bloodstream.
Sources
- Ryan L, Symington AM. Algal-oil supplements are a viable alternative to fish-oil supplements in terms of docosahexaenoic acid. J Funct Foods. 2015;14:264-270. DOI
- Dyerberg J et al. Bioavailability of marine n-3 fatty acid formulations. Prostaglandins Leukot Essent Fatty Acids. 2010;83(3):137-141. PubMed
- Pressman P et al. Bioavailability of micronutrients obtained from supplements and food. Toxicol Res Appl. 2017;1:1-4. DOI
Cara Hayes, MSc Nutrition and Dietetics (University of Sydney), writes all content in the Phytality Knowledge Centre. Read our editorial policy.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Consult your GP or a qualified healthcare professional before starting any supplement.
Methodology and Disclosure
Algae DHA bioequivalence cites Ryan and Symington 2015 (J Funct Foods). Omega-3 formulation bioavailability cites Dyerberg et al. 2010 (Prostaglandins Leukot Essent Fatty Acids). Micronutrient bioavailability framework cites Pressman et al. 2017 (Toxicol Res Appl). Chlorella digestibility figures reflect published feeding study data.
Vendor disclosure: Phytality manufactures algae supplements. This article examines bioavailability claims across the supplement industry. We have a commercial interest in our evidence restraint being understood as a quality signal. The absence of product-specific bioavailability trials for our products has been stated directly.
Last reviewed: April 2026